The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
<p><strong>Background</strong><br/> The discovery that voltage-gated calcium channel genes such as CACNA1C are part of the aetiology of psychiatric disorders has rekindled interest in the therapeutic potential of L-type calcium channel (LTCC) antagonists. These drugs, license...
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
BioMed Central
2019
|